Aktis Oncology, Inc. (AKTS)
NASDAQ: AKTS · Real-Time Price · USD
24.60
+0.64 (2.67%)
Jul 21, 2026, 11:56 AM EDT - Market open
Aktis Oncology Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Reiterates $30 → $33 | Buy | Reiterates | $30 → $33 | +34.15% | Jul 14, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 14, 2026 |
| Raymond James | Raymond James | Buy Initiates $40 | Buy | Initiates | $40 | +62.60% | Jun 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $35 | Buy | Reiterates | $35 | +42.28% | Jun 2, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $34 | Buy | Maintains | $34 | +38.21% | Jun 1, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 11, 2026 |
| Leerink Partners | Leerink Partners | Buy Initiates $31 | Buy | Initiates | $31 | +26.02% | Feb 3, 2026 |